Virginia Biotechnology Association

News

Intrexon Secures $25M VC Round

Intrexon Corporation, a privately-held life sciences company focused on biotherapeutic control systems, announced it has closed a $25 million Series C-2 financing by New River Management V, LP, a private investment fund managed by Third Security,... read more ».

Members Named to Legislative Biotech Subcommittee

The members of the Virginia General Assembly’s Joint Subcommittee on Biotechnology and the Biosciences were named last week by the Speaker of the House, Bill Howell, and the Rules Committee of the Virginia State Senate. The subcommittee,... read more ».

BIO Wins Major Vote on Stimulus for Biotech Companies

On April 4th, the U.S. Senate passed by a vote of 76 to 2 an amendment offered by Senators George Voinovich (R-OH) and Debbie Stabenow (D-MI) that would benefit many emerging biotechnology companies that are not-yet-profitable but have accumulated... read more ».

Obetech Signs Major Deal for Obesity-related Virus AD36

Obetech LLC, a Richmond, Virginia-based biotechnology company, has signed a world-wide license agreement for the patent rights to the obesity-related virus adenovirus 36 (AD36) with Scandinavian Clinical Nutrition (SCN) of Stockholm, Sweden. The... read more ».

Combination Drug Therapy May Hold the Key to Reversing Type...

Diakine Therapeutics, a Charlottesville-based biotechnology firm, announced that new research shows that one of their drugs, used in combination therapy, could reverse type 1 diabetes. According to the company, seventy percent of mice with type 1... read more ».

Israeli Bioscience Firm Opens US Office in Richmond

EnzySurge, an Israeli bioscience company focused on chronic wound management, announced that they will establish their U.S. office at the Virginia BioTechnology Research Park, in Richmond. EnzySurge will join several other Israeli firms as a member... read more ».

Diffusion Pharma Wins Patent for its Family of...

Diffusion Pharmaceuticals LLC, a Charlottesville-based clinical-stage drug-development company commercializing drugs utilizing a novel method of action that enhances oxygen diffusion, announced that it has been granted U.S. patent no. 7,351,844... read more ».

Commonwealth Biotechnologies Lands Strategic Investor

Commonwealth Biotechnologies, Inc. (CBI), of Richmond, Virginia, announced that Venturepharm Laboratories Ltd (VPL) has become a cornerstone investor through the purchase of 2.15M shares from PharmAust Ltd, which represents 39% of CBI’s ... read more ».

Insmed Continues Fight for Generic Biologic Approval

Insmed Inc., a Richmond, Virginia-based developer of follow-on biologics and biopharmaceuticals, announced receipt of a letter and questionnaire from the Chairman and Ranking Member of the U.S. House of Representatives’ Subcommittee on... read more ».

Top Prizes for Biotech Awarded at State Science Fair

The Virginia Biotechnology Association (VaBIO) presented awards at the 2008 Virginia State Science and Engineering Fair on Saturday, April 12, 2008, at George Mason University in Fairfax. The awards were presented in the name of the Chesapeake... read more ».